The U.S. Food and Drug Administration has approved the first prodrug designed for once-daily treatment of adults with ADHD.
Although ADHD -- attention deficit-hyperactivity disorder -- is often thought of as a childhood malady, it's estimated 4.4 percent of U.S. adults ages 18-to-44 suffer from it. The new drug, Vyvanse, has been marketed in the United States since July 2007 for the treatment of ADHD in children 6-12 years of age.
The manufacturer, Shire PLC, a British-headquartered specialty biopharmaceutical company, said Vyvanse is the only once-daily prodrug stimulant approved to treat adults with ADHD. A prodrug is a medication designed to be inactive until it interacts with enzymes in the stomach, thereby making it difficult to be abused, a Shire spokesman said.
In a clinical study with adults, Vyvanse was shown to significantly improve ADHD symptoms, such as an inability to focus attention, hyperactivity and impulsivity, within the first week of use, Shire officials said.
The company said Vyvanse is now available in dosage strengths of 30 mg, 50 mg and 70 mg. Additional dosage strengths of 20 mg, 40 mg and 60 mg are expected to become available later this year.
Copyright 2008 by United Press International
Related stories:
Knowing looks: Using gaze aversion to tell when children are learning
People use eye contact in a variety of ways every minute of every day but how often do you find yourself staring into space with concentrating on an issue or problem? Psychologists now know that people who are carrying out a complex task tend to look away from anyone else who is nearby. They refer to it as 'gaze aversion'.
People with ADHD do 1 month's less work per year
Workers with attention deficit hyperactivity disorder (ADHD) do 22 days less work per year than people who do not have the disorder, finds research published online ahead of print in
Occupational and Environmental Medicine.
Children more vulnerable to harmful effects of lead
Contrary to prevailing assumptions, children are more vulnerable to the harmful effects of lead exposure at the age of 6 than they are in early childhood, according to a Cincinnati Children’s Hospital Medical Center study to be presented May 4 at the annual meeting of the Pediatric Academic Societies in Honolulu.
Preschool kids do better when they talk to themselves, research shows
Parents should not worry when their pre-schoolers talk to themselves; in fact, they should encourage it, says Adam Winsler, an associate professor of psychology at George Mason University. His recent study published in
Early Childhood Research Quarterly showed that 5-year-olds do better on motor tasks when they talk to themselves out loud (either spontaneously or when told to do so by an adult) than when they are silent.
Heavy drinking, conduct disorder linked to high-risk sexual behavior
Psychiatry researchers at Washington University School of Medicine in St. Louis have found that a clinical diagnosis of alcohol dependence in young adults is associated with having a high number of sex partners.
Brain matures a few years late in ADHD, but follows normal pattern
In youth with attention deficit hyperactivity disorder (ADHD), the brain matures in a normal pattern but is delayed three years in some regions, on average, compared to youth without the disorder, an imaging study by researchers at the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH) has revealed.
Adult ADHD linked with dopamine levels
Adults with attention-deficit/hyperactivity disorder have a reduced response to the drug Ritalin, U.S. government scientists have found.
ADHD appears to be associated with depressed dopamine activity in the brain
Adults with attention-deficit/hyperactivity disorder (ADHD) show a blunted response to the drug methylphenidate (Ritalin), which increases brain dopamine levels, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. This suggests that dopamine dysfunction may be involved with ADHD symptoms and may contribute to substance abuse that often occurs simultaneously.